Taxanes for the treatment of breast cancer during pregnancy: an international cohort study.
Ana S Ferrigno GuajardoBryan F Vaca-CartagenaErica L MayerChayma BousrihOke OluchiCristina SauraFedro Alessandro PeccatoriWendy R Muñoz-MontañoAlvaro Cabrera-GarciaMatteo LambertiniLuis CorralesAndrea Becerril-GaitanTal SellaAlexandra Bili NewmanBarbara PistilliAshley MartinezCarolina OrtizLaia Joval-RamentolGiovanna ScarfoneBarbara BuonomoFernando Lara-MedinaJacqueline SanchezLuca AreccoAllan Ramos-EsquivelSnezana SusnjarGilberto MorganCynthia Villarreal GarzaHatem A AzimPublished in: Journal of the National Cancer Institute (2023)
Obstetric and neonatal outcomes after taxane exposure during pregnancy were generally favorable and did not seem to differ from those reported in the literature with standard anthracycline-based regimens. This study supports the use of taxanes during gestation when clinically indicated.